Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.

Lindström U, Glintborg B, Di Giuseppe D, Nordström D, Aarrestad Provan S, Gudbjornsson B, Askling J, Lund Hetland M, Aaltonen K, Krogh NS, Geirsson AJ, Jacobsson LTH.

RMD Open. 2019 Oct 23;5(2):e001079. doi: 10.1136/rmdopen-2019-001079. eCollection 2019.

2.

Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.

Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML.

Rheumatology (Oxford). 2019 Oct 30. pii: kez427. doi: 10.1093/rheumatology/kez427. [Epub ahead of print]

PMID:
31665497
3.

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, Kristianslund EK, Nordström D, Santos MJ, Codreanu C, Gómez-Reino J, Rotar Z, Gudbjornsson B, Di Giuseppe D, Nissen MJ, Pavelka K, Birlik M, Kvien T, Eklund KK, Barcelos A, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Loft AG, van der Horst-Bruinsma I, Jones G, Iannone F, Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.

Ann Rheum Dis. 2019 Nov;78(11):1536-1544. doi: 10.1136/annrheumdis-2019-215427. Epub 2019 Aug 20.

PMID:
31431486
4.

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible.

Palsson O, Love TJ, Gunnarsdottir AI, Gunnarsson PS, Runarsdottir EE, Krogh NS, Gudbjornsson B.

RMD Open. 2019 Jul 16;5(2):e000984. doi: 10.1136/rmdopen-2019-000984. eCollection 2019.

5.

[Pregnancy outcomes in Icelandic female patients with inflammatory arthritides. Nationwide results from the ICEBIO and the Icelandic Medical Birth Register].

Kristjansdottir SR, Steingrimsdottir T, Grondal G, Bjarnadóttir RI, Einarsdottir K, Gudbjornsson B.

Laeknabladid. 2019 Jun;105(6):267-275. doi: 10.17992/lbl.2019.06.235. Icelandic.

6.

Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study.

Gudmundsson HT, Hansen KE, Halldorsson BV, Ludviksson BR, Gudbjornsson B.

BMC Med Inform Decis Mak. 2019 Feb 1;19(1):27. doi: 10.1186/s12911-019-0749-4.

7.

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries.

Glintborg B, Lindström U, Aaltonen K, Kristianslund EK, Gudbjornsson B, Chatzidionysiou K, Askling J, Nordström D, Hetland ML, Di Giuseppe D, Dreyer L, Kristensen LE, Jørgensen TS, Eklund K, Grondal G, Ernestam S, Joensuu J, Törmänen M, Skydsgaard H, Hagfors J, Kvien TK, Lie E, Fagerli K, Geirsson AJ, Jonsson H, Provan SA, Krogh NS, Jacobsson L.

Scand J Rheumatol. 2018 Nov;47(6):465-474. doi: 10.1080/03009742.2018.1444199. Epub 2018 Aug 2.

PMID:
30070923
8.

The majority of patients with psoriatic arthritis are not eligible for randomised clinical trials.

Runarsdottir EE, Gunnarsdottir AI, Love TJ, Gunnarsson PS, Gudbjornsson B; ICEBIO.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1068-1073. Epub 2018 Jun 14.

10.

[Screening for tuberculosis before TNFα treatment in routine rheumatic care in Iceland. Result from the nationwide ICEBIO registry].

Bjorgulfsson TM, Gröndal G, Blondal T, Gudbjornsson B.

Laeknabladid. 2018 Mai;104(5):231-235. doi: 10.17992/lbl.2018.05.184. Icelandic.

11.

[Gout - a treatable condition].

Johannsdottir GA, Palsson O, Jonsson H, Gudbjornsson B.

Laeknabladid. 2018 Apr;104(4):177-186. doi: 10.17992/lbl.2018.04.181. Icelandic.

12.

Corrigendum to "A Clinical Decision Support System for the Diagnosis, Fracture Risks and Treatment of Osteoporosis".

Halldorsson BV, Bjornsson AH, Gudmundsson HT, Birgisson EO, Ludviksson BR, Gudbjornsson B.

Comput Math Methods Med. 2017;2017:5472789. doi: 10.1155/2017/5472789. Epub 2017 Jun 29.

13.

Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids.

Björnsson ES, Bergmann O, Jonasson JG, Grondal G, Gudbjornsson B, Olafsson S.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1635-1636. doi: 10.1016/j.cgh.2017.05.027. Epub 2017 May 20. No abstract available.

PMID:
28535988
14.

GRAPPA Trainees Symposium 2016: A Report from the GRAPPA 2016 Annual Meeting.

Polachek A, Stober CB, Gudbjornsson B, Ritchlin CT.

J Rheumatol. 2017 May;44(5):661-667. doi: 10.3899/jrheum.170140.

PMID:
28461521
15.

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study.

Glinatsi D, Heiberg MS, Rudin A, Nordström D, Haavardsholm EA, Gudbjornsson B, Østergaard M, Uhlig T, Grondal G, Hørslev-Petersen K, van Vollenhoven R, Hetland ML.

Trials. 2017 Apr 4;18(1):161. doi: 10.1186/s13063-017-1891-x.

16.

Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study.

Lindqvist U, Gudbjornsson B, Iversen L, Laasonen L, Ejstrup L, Ternowitz T, Ståhle M.

Scand J Rheumatol. 2017 Nov;46(6):454-460. doi: 10.1080/03009742.2017.1278787. Epub 2017 Feb 10.

PMID:
28276958
17.

Eight-year follow-up of airway hyperresponsiveness in patients with primary Sjögren's syndrome.

Ludviksdottir D, Valtysdottir ST, Hedenström H, Hällgren R, Gudbjörnsson B.

Ups J Med Sci. 2017 Mar;122(1):51-55. doi: 10.1080/03009734.2016.1239663. Epub 2016 Nov 16.

18.

The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries.

Højgaard P, Glintborg B, Kristensen LE, Gudbjornsson B, Love TJ, Dreyer L.

Rheumatology (Oxford). 2016 Dec;55(12):2191-2199. Epub 2016 Sep 19.

PMID:
27651526
19.

Activation of Complement Following Total Hip Replacement.

Thordardottir S, Vikingsdottir T, Bjarnadottir H, Jonsson H Jr, Gudbjornsson B.

Scand J Immunol. 2016 Mar;83(3):219-24. doi: 10.1111/sji.12411.

20.

Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.

Gudbjornsson BT, Haraldsson Á, Einarsdóttir H, Thorarensen Ó.

Pediatr Neurol. 2015 Dec;53(6):503-7. doi: 10.1016/j.pediatrneurol.2015.08.020. Epub 2015 Sep 5.

PMID:
26463471
21.

Radiographic development during three decades in a patient with psoriatic arthritis mutilans.

Laasonen L, Gudbjornsson B, Ejstrup L, Iversen L, Ternowitz T, Ståhle M, Lindqvist U.

Acta Radiol Open. 2015 Jul 6;4(7):2058460115588098. doi: 10.1177/2058460115588098. eCollection 2015 Jul.

22.

A clinical decision support system for the diagnosis, fracture risks and treatment of osteoporosis.

Halldorsson BV, Bjornsson AH, Gudmundsson HT, Birgisson EO, Ludviksson BR, Gudbjornsson B.

Comput Math Methods Med. 2015;2015:189769. doi: 10.1155/2015/189769. Epub 2015 Mar 1. Erratum in: Comput Math Methods Med. 2017;2017:5472789.

23.

Risk of drug-induced liver injury from tumor necrosis factor antagonists.

Björnsson ES, Gunnarsson BI, Gröndal G, Jonasson JG, Einarsdottir R, Ludviksson BR, Gudbjörnsson B, Olafsson S.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):602-8. doi: 10.1016/j.cgh.2014.07.062. Epub 2014 Aug 15.

PMID:
25131534
24.

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.

Glintborg B, Gudbjornsson B, Krogh NS, Omerovic E, Manilo N, Holland-Fischer M, Lindegaard HM, Loft AG, Nordin H, Johnsen L, Oeftiger SF, Hansen A, Rasmussen C, Grondal G, Geirsson AJ, Hetland ML.

Rheumatology (Oxford). 2014 Nov;53(11):2100-9. doi: 10.1093/rheumatology/keu252. Epub 2014 Jun 17.

PMID:
24939677
25.

Arthritis mutilans: a report from the GRAPPA 2012 annual meeting.

Chandran V, Gladman DD, Helliwell PS, Gudbjörnsson B.

J Rheumatol. 2013 Aug;40(8):1419-22. doi: 10.3899/jrheum.130453.

PMID:
23908536
26.

Sarcoid arthropathy and the association with the human leukocyte antigen. The Icelandic Sarcoidosis Study.

Petursdottir D, Haraldsdottir SO, Bjarnadottir K, Jonsson T, Gislason T, Gudmundsson S, Gudbjornsson B.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):711-6. Epub 2013 May 27.

PMID:
23711303
27.

Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study.

Gudbjornsson B, Ejstrup L, Gran JT, Iversen L, Lindqvist U, Paimela L, Ternowitz T, Ståhle M.

Scand J Rheumatol. 2013;42(5):373-8. doi: 10.3109/03009742.2013.771211. Epub 2013 Mar 21.

PMID:
23514454
28.

Psoriatic arthritis and onycholysis -- results from the cross-sectional Reykjavik psoriatic arthritis study.

Love TJ, Gudjonsson JE, Valdimarsson H, Gudbjornsson B.

J Rheumatol. 2012 Jul;39(7):1441-4. doi: 10.3899/jrheum.111298. Epub 2012 May 15.

PMID:
22589259
29.

Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study.

Love TJ, Gudjonsson JE, Valdimarsson H, Gudbjornsson B.

Scand J Rheumatol. 2010 Aug;39(4):299-302. doi: 10.3109/03009741003604559.

PMID:
20476857
30.

A strong familiality of ankylosing spondylitis through several generations.

Geirsson AJ, Kristjansson K, Gudbjornsson B.

Ann Rheum Dis. 2010 Jul;69(7):1346-8. doi: 10.1136/ard.2009.125914. Epub 2010 May 6.

PMID:
20448282
31.

Prevalence and clinical characteristics of ankylosing spondylitis in Iceland - a nationwide study.

Geirsson AJ, Eyjolfsdottir H, Bjornsdottir G, Kristjansson K, Gudbjornsson B.

Clin Exp Rheumatol. 2010 May-Jun;28(3):333-40. Epub 2010 Jun 23.

PMID:
20406616
32.

[Giant cell arteritis - two cases with acute blindness].

Elfarsson A, Gudbjörnsson B, Stefánsson E.

Laeknabladid. 2010 Mar;96(3):185-9. doi: 10.17992/lbl.2010.03.281. Icelandic.

PMID:
20197597
33.

Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.

Gudbjornsson B, Thorsteinsson SB, Sigvaldason H, Einarsdottir R, Johannsson M, Zoega H, Halldorsson M, Thorgeirsson G.

Eur J Clin Pharmacol. 2010 Jun;66(6):619-25. doi: 10.1007/s00228-010-0789-2. Epub 2010 Feb 16.

PMID:
20157701
34.

A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study.

Karason A, Love TJ, Gudbjornsson B.

Rheumatology (Oxford). 2009 Nov;48(11):1424-8. doi: 10.1093/rheumatology/kep243. Epub 2009 Sep 9.

PMID:
19741010
35.

Diurnal rhythm of cytokines in rheumatoid arthritis may be reflected in in vitro cultures of collected mononuclear cells.

Johannsdottir K, Gudbjornsson B.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5):969. No abstract available.

PMID:
19032841
36.

Are ethics rules too strict in retrospective clinical studies?

Stefánsson E, Atladóttir OY, Gudbjornsson B.

Acta Ophthalmol. 2008 Sep;86(6):588-90. doi: 10.1111/j.1755-3768.2008.01413.x. No abstract available. Erratum in: Acta Ophthalmol. 2008 Nov;86(7):816. Guğbjörnsson, Björn [corrected to Gudbjornsson, Bjorn].

37.

Clinical manifestation, prevalence and prognosis of sarcoid arthropathy. A nationwide study: the Icelandic Sarcoidosis Study.

Petursdottir D, Haraldsdottir SO, Gislason T, Gudbjornsson B.

Sarcoidosis Vasc Diffuse Lung Dis. 2007 Sep;24(2):113-20.

PMID:
18496981
38.

Rib cage motion in ankylosing spondylitis patients: a pilot study.

Ragnarsdottir M, Geirsson AJ, Gudbjornsson B.

Spine J. 2008 May-Jun;8(3):505-9. doi: 10.1016/j.spinee.2006.12.009. Epub 2007 Feb 20.

PMID:
18455114
39.

[Bone mineral density and bone turnover in systemic sclerosis].

Alexandersson BT, Geirsson AJ, Olafsson I, Franzson L, Sigurdsson G, Gudbjornsson B.

Laeknabladid. 2007 Jul-Aug;93(7-8):535-41. Icelandic.

PMID:
17823496
40.

Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course.

Love TJ, Gudbjornsson B, Gudjonsson JE, Valdimarsson H.

J Rheumatol. 2007 Oct;34(10):2082-8. Epub 2007 Aug 1.

PMID:
17696270
41.

Inflammatory cytokines in relation to adrenal response following total hip replacement.

Bjornsson GL, Thorsteinsson L, Gudmundsson KO, Jonsson H Jr, Gudmundsson S, Gudbjornsson B.

Scand J Immunol. 2007 Jan;65(1):99-105.

42.

[The prevalence of sicca symptoms in Iceland.].

Atladóttir J, Guðmundsson OG, Holbrook P, Sigurðsson R, Gudbjornsson B.

Laeknabladid. 2000 Dec;86(12):859-65. Icelandic.

PMID:
17018970
43.

[COX-II or NSAIDs - benefits? [Editorial].].

Gudbjornsson B.

Laeknabladid. 2000 Nov;86(11):739-41. Icelandic. No abstract available.

PMID:
17018960
44.

[Deep vein thrombosis incidence at Akureyri Hospital, Iceland 1975-1990. Long term prognosis.].

Karlsson G, Riba P, Thoroddsson I, Gudbjornsson B.

Laeknabladid. 2000 Jan;86(1):19-24. Icelandic.

PMID:
17018905
45.

[Community use of oral glucocorticosteroids in Iceland and prophylactic treatment for steroid-induced osteoporosis in daily clinical pratice.].

Júlíusson UI, Guðjónsson FV, Gudbjornsson B.

Laeknabladid. 2001 Jan;87(1):23-9. Icelandic.

PMID:
16940681
46.

[Prevention and treatment of corticosteroid induced osteoporosis. Clinical Guidelines.].

Guðmundsson A, Helgason S, Gudbjornsson B.

Laeknabladid. 2002 Feb;88(2):101-7. Icelandic.

PMID:
16940654
47.
49.

Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome.

Amin K, Lúdvíksdóttir D, Janson C, Nettelbladt O, Gudbjörnsson B, Valtysdóttir S, Björnsson E, Roomans GM, Boman G, Sevéus L, Venge P; BHR-Group. Bronchial hyper-responsiveness.

Respir Med. 2001 Nov;95(11):904-10.

50.

Sleep disturbances in patients with systemic lupus erythematosus: a questionnaire-based study.

Gudbjörnsson B, Hetta J.

Clin Exp Rheumatol. 2001 Sep-Oct;19(5):509-14.

PMID:
11579709

Supplemental Content

Loading ...
Support Center